Copanlisib
Drug timelines are a Plus or Pro feature.
37 regulatory and trial events tracked for Copanlisib, covering 2014-10-28 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma [Phase 1, Phase 2]